Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO + G-CSF for Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma
ChiCTR-IIR-17010787Phase 2Completed
- Sponsor
- Shanghai General Hospital
- Start
- Dec 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of recombinant human thrombopoietin and granulocyte colony-stimulating factor in lymphoma (2 arms), sponsored by Shanghai General Hospital. Primary endpoints: nucleated cell count collected for APBSC, CD34+ cell count collected for APBSC and 1 more. Started Dec 2010; status: completed.
02
Drugs
recombinant human thrombopoietingranulocyte colony-stimulating factor
03
Conditions
lymphoma
Beyond the preview
Go deeper on ChiCTR-IIR-17010787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17010787.